Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017 (2017), Article ID 7454376, 12 pages
https://doi.org/10.1155/2017/7454376
Review Article

The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review

1Department of Health Sciences, Vrije Universiteit Amsterdam and the Amsterdam Public Health Research Institute, Amsterdam, Netherlands
2Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
3Department of Epidemiology and Biostatistics, VU University Medical Center and the Amsterdam Public Health Research Institute, Amsterdam, Netherlands
4Bad Gleichenberg Clinic, Bad Gleichenberg, Austria
5Department of Cardiology, Swiss Cardiovascular Center Bern, Bern University Hospital, University of Bern, Bern, Switzerland
6Department of Cardiology, Medical University of Graz, Graz, Austria

Correspondence should be addressed to Adriana J. van Ballegooijen; ln.uv@nejioogellab.nav.ennah

Received 2 June 2017; Accepted 17 August 2017; Published 12 September 2017

Academic Editor: Constantinos Pantos

Copyright © 2017 Adriana J. van Ballegooijen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Skeie, T. Braaten, A. Hjartaker et al., “Use of dietary supplements in the European prospective investigation into cancer and nutrition calibration study,” European Journal of Clinical Nutrition, vol. 63, Supplement 4, pp. S226–S238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Spiro and J. L. Buttriss, “Vitamin D: an overview of vitamin D status and intake in Europe,” Nutrition Bulletin, vol. 39, pp. 322–350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. EFSA Panel on Dietetic Products, NaA, “Scientific opinion on the tolerable upper intake level of vitamin D,” EFSA Journal, vol. 10, p. 2813, 2012. View at Google Scholar
  4. A. Zittermann, J. B. Ernst, S. Prokop et al., “Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily,” European Heart Journal, vol. 38, no. 29, pp. 2279–2286, 2017. View at Publisher · View at Google Scholar
  5. J. S. Adams, B. Rafison, S. Witzel et al., “Regulation of the extrarenal CYP27B1-hydroxylase,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 144, Part A, pp. 22–27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Dusso, A. Brown, and E. Slatopolsky, “Extrarenal production of calcitriol,” Seminars in Nephrology, vol. 14, pp. 144–155, 1994. View at Google Scholar
  7. H. S. Cross and E. Kallay, “Nutritional regulation of extrarenal vitamin D hydroxylase expression - potential application in tumor prevention and therapy,” Future Oncology, vol. 1, pp. 415–424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. Fleet, “The role of vitamin D in the endocrinology controlling calcium homeostasis,” Molecular and Cellular Endocrinology, vol. 17, pp. 30221–30226, 2017. View at Publisher · View at Google Scholar
  9. G. Bjelakovic, L. L. Gluud, D. Nikolova et al., “Vitamin D supplementation for prevention of mortality in adults,” Cochrane Database of Systematic Reviews, article CD007470, 2014. View at Publisher · View at Google Scholar
  10. A. Avenell, J. C. Mak, and D. O'Connell, “Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men,” Cochrane Database of Systematic Reviews, article CD000227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. J. Bolland, A. Grey, A. Avenell, G. D. Gamble, and I. R. Reid, “Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis,” British Medical Journal, vol. 342, article d2040, 2011. View at Google Scholar
  12. I. Thiele, J. Linseisen, C. Meisinger et al., “Associations between calcium and vitamin D supplement use as well as their serum concentrations and subclinical cardiovascular disease phenotypes,” Atherosclerosis, vol. 241, pp. 743–751, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Challoumas, A. Stavrou, A. Pericleous, and G. Dimitrakakis, “Effects of combined vitamin D--calcium supplements on the cardiovascular system: should we be cautious?” Atherosclerosis, vol. 238, pp. 388–398, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. R. B. Wallace, J. Wactawski-Wende, M. J. O'Sullivan et al., “Urinary tract stone occurrence in the Women’s Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements,” The American Journal of Clinical Nutrition, vol. 94, pp. 270–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. L. Booth and A. Rajabi, “Determinants of vitamin K status in humans,” Vitamins and Hormones, vol. 78, pp. 1–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Shearer and P. Newman, “Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis,” Journal of Lipid Research, vol. 55, pp. 345–362, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Lanham-New, “Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment,” The Proceedings of the Nutrition Society, vol. 67, pp. 163–176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Turck, J. L. Bresson, B. Burlingame et al., “EFSA panel on dietetic products, nutrition and allergies. Dietary reference values for vitamin K,” EFSA Journal, vol. 15, p. 4780, 2017. View at Google Scholar
  19. S. L. Booth, G. Dallal, M. K. Shea, C. Gundberg, J. W. Peterson, and B. Dawson-Hughes, “Effect of vitamin K supplementation on bone loss in elderly men and women,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, pp. 1217–1223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. J. Ballegooijen and J. W. Beulens, “The role of vitamin K status in cardiovascular health: evidence from observational and clinical studies,” Current Nutrition Reports, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  21. X. Fu, X. D. Wang, H. Mernitz, R. Wallin, M. K. Shea, and S. L. Booth, “9-cis retinoic acid reduces 1alpha,25-dihydroxycholecalciferol-induced renal calcification by altering vitamin K-dependent gamma-carboxylation of matrix gamma-carboxyglutamic acid protein in A/J male mice,” The Journal of Nutrition, vol. 138, pp. 2337–2341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. N. C. Arbour, H. M. Darwish, and H. F. DeLuca, “Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24-epimer in rat osteosarcoma cells,” Biochimica et Biophysica Acta, vol. 1263, pp. 147–153, 1995. View at Google Scholar
  23. Y. Seyama, M. Horiuch, M. Hayashi, and Y. Kanke, “Effect of vitamin K2 on experimental calcinosis induced by vitamin D2 in rat soft tissue,” International Journal for Vitamin and Nutrition Research, vol. 66, pp. 36–38, 1996. View at Google Scholar
  24. E. C. Breen, A. J. Wijnen, J. B. Lian, G. S. Stein, and J. L. Stein, “In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, pp. 12902–12906, 1994. View at Google Scholar
  25. J. D. Fraser and P. A. Price, “Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells,” Calcified Tissue International, vol. 46, pp. 270–279, 1990. View at Google Scholar
  26. N. Miyake, K. Hoshi, Y. Sano, K. Kikuchi, K. Tadano, and Y. Koshihara, “1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts,” Osteoporosis International, vol. 12, pp. 680–687, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. P. I. Karl, D. L. Carnes, and P. A. Friedman, “Effects of 1,25-dihydroxycholecalciferol administration on the rat renal vitamin K-dependent carboxylating system,” FEBS Letters, vol. 192, pp. 243–246, 1985. View at Google Scholar
  28. D. D. Bikle, “Vitamin D metabolism, mechanism of action, and clinical applications,” Chemistry & Biology, vol. 21, pp. 319–329, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Koshihara and K. Hoshi, “Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro,” Journal of Bone and Mineral Research, vol. 12, pp. 431–438, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. P. A. Price and S. A. Baukol, “1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells,” The Journal of Biological Chemistry, vol. 255, pp. 11660–11663, 1980. View at Google Scholar
  31. P. A. Price and S. A. Baukol, “1,25-dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone protein,” Biochemical and Biophysical Research Communications, vol. 99, pp. 928–935, 1981. View at Publisher · View at Google Scholar · View at Scopus
  32. S. A. Kerner, R. A. Scott, and J. W. Pike, “Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, pp. 4455–4459, 1989. View at Google Scholar
  33. Y. Koshihara, K. Hoshi, H. Ishibashi, and M. Shiraki, “Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts,” Calcified Tissue International, vol. 59, pp. 466–473, 1996. View at Google Scholar
  34. I. N. Sergeev and A. W. Norman, “Vitamin K-dependent gamma-carboxylation of the 1,25-dihydroxyvitamin D3 receptor,” Biochemical and Biophysical Research Communications, vol. 189, pp. 1543–1547, 1992. View at Google Scholar
  35. R. Sanguineti, F. Monacelli, A. Parodi et al., “Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts,” Journal of Biological Regulators and Homeostatic Agents, vol. 30, pp. 713–726, 2016. View at Google Scholar
  36. A. Gigante, M. Torcianti, E. Boldrini et al., “Vitamin K and D association stimulates in vitro osteoblast differentiation of fracture site derived human mesenchymal stem cells,” Journal of Biological Regulators and Homeostatic Agents, vol. 22, pp. 35–44, 2008. View at Google Scholar
  37. K. Hara, Y. Akiyama, T. Tomiuga, M. Kobayashi, T. Nakamura, and T. Tajima, “Influence of vitamin D3 on inhibitory effect of vitamin K2 on bone loss in ovariectomized rats,” Nihon Yakurigaku Zasshi, vol. 104, pp. 101–109, 1994. View at Google Scholar
  38. S. Matsunaga, H. Ito, and T. Sakou, “The effect of vitamin K and D supplementation on ovariectomy-induced bone loss,” Calcified Tissue International, vol. 65, pp. 285–289, 1999. View at Google Scholar
  39. J. Iwamoto, A. Seki, Y. Sato, H. Matsumoto, T. Tadeda, and J. K. Yeh, “Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatment,” Calcified Tissue International, vol. 86, pp. 234–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Fusaro, S. Giannini, M. Gallieni et al., “Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins,” Endocrine, vol. 51, pp. 333–341, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Tamatani, S. Morimoto, M. Nakajima et al., “Decreased circulating levels of vitamin K and 25-hydroxyvitamin D in osteopenic elderly men,” Metabolism, vol. 47, pp. 195–199, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. A. C. Torbergsen, L. O. Watne, T. B. Wyller et al., “Vitamin K1 and 25(OH)D are independently and synergistically associated with a risk for hip fracture in an elderly population: a case control study,” Clinical Nutrition, vol. 34, pp. 101–106, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. T. E. Finnes, C. M. Lofthus, H. E. Meyer et al., “A combination of low serum concentrations of vitamins K1 and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study,” Osteoporosis International, vol. 27, pp. 1645–1652, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Vignini, L. Nanetti, F. Raffaelli et al., “Effect of supplementation with fortified olive oil on biochemical markers of bone turnover in healthy women,” Mediterranean Journal of Nutrition and Metabolism, vol. 1, pp. 117–120, 2008. View at Publisher · View at Google Scholar
  45. T. Ushiroyama, A. Ikeda, and M. Ueki, “Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women,” Maturitas, vol. 41, pp. 211–221, 2002. View at Google Scholar
  46. J. Iwamoto, T. Takeda, and S. Ichimura, “Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis,” Journal of Orthopaedic Science, vol. 5, pp. 546–551, 2000. View at Google Scholar
  47. C. Bolton-Smith, M. E. McMurdo, C. R. Paterson et al., “Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women,” Journal of Bone and Mineral Research, vol. 22, pp. 509–519, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. L. A. Braam, M. H. Knapen, P. Geusens et al., “Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age,” Calcified Tissue International, vol. 73, pp. 21–26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. S. H. Je, N. S. Joo, B. H. Choi et al., “Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old,” Journal of Korean Medical Science, vol. 26, pp. 1093–1098, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Mazzanti, M. Battino, L. Nanetti et al., “Effect of 1-year dietary supplementation with vitaminized olive oil on markers of bone turnover and oxidative stress in healthy post-menopausal women,” Endocrine, vol. 50, pp. 326–334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Sato, T. Kanoko, K. Satoh, and J. Iwamoto, “Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer’s disease,” Bone, vol. 36, pp. 61–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. E. M. O'Connor, G. Grealy, J. McCarthy et al., “Effect of phylloquinone (vitamin K1) supplementation for 12 months on the indices of vitamin K status and bone health in adult patients with Crohn’s disease,” The British Journal of Nutrition, vol. 112, pp. 1163–1174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Binkley, J. Harke, D. Krueger et al., “Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women,” Journal of Bone and Mineral Research, vol. 24, pp. 983–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Cheung, L. Tile, Y. Lee et al., “Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial,” PLoS Medicine, vol. 5, article e196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Yonemura, H. Fukasawa, Y. Fujigaki, and A. Hishida, “Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine,” American Journal of Kidney Diseases, vol. 43, pp. 53–60, 2004. View at Google Scholar
  56. L. J. Schurgers, E. C. Cranenburg, and C. Vermeer, “Matrix Gla-protein: the calcification inhibitor in need of vitamin K,” Thrombosis and Haemostasis, vol. 100, pp. 593–603, 2008. View at Google Scholar
  57. P. A. Price, S. A. Faus, and M. K. Williamson, “Warfarin-induced artery calcification is accelerated by growth and vitamin D,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, pp. 317–327, 2000. View at Google Scholar
  58. O. Mayer Jr., J. Seidlerova, P. Wohlfahrt et al., “Synergistic effect of low K and D vitamin status on arterial stiffness in a general population,” The Journal of Nutritional Biochemistry, vol. 46, pp. 83–89, 2017. View at Publisher · View at Google Scholar
  59. A. J. Ballegooijen, A. Cepelis, M. Visser, I. A. Brouwer, N. M. Schoor, and J. W. Beulens, “Joint association of low vitamin D and vitamin K status with blood pressure and hypertension,” Hypertension, vol. 69, pp. 1165–1172, 2017. View at Publisher · View at Google Scholar
  60. L. A. Braam, A. P. Hoeks, F. Brouns, K. Hamulyák, M. J. Gerichhausen, and C. Vermeer, “Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study,” Thrombosis and Haemostasis, vol. 91, pp. 373–380, 2004. View at Publisher · View at Google Scholar
  61. M. K. Shea, C. J. O'Donnell, U. Hoffmann et al., “Vitamin K supplementation and progression of coronary artery calcium in older men and women,” The American Journal of Clinical Nutrition, vol. 89, pp. 1799–1807, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. Z. Asemi, F. Raygan, F. Bahmani et al., “The effects of vitamin D, K and calcium co-supplementation on carotid intima-media thickness and metabolic status in overweight type 2 diabetic patients with CHD,” The British Journal of Nutrition, vol. 116, pp. 286–293, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. I. Kurnatowska, P. Grzelak, A. Masajtis-Zagajewska et al., “Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5,” Polskie Archiwum Medycyny Wewnętrznej, vol. 125, pp. 631–640, 2015. View at Google Scholar
  64. I. Kurnatowska, P. Grzelak, A. Masajtis-Zagajewska et al., “Plasma desphospho-uncarboxylated matrix Gla protein as a marker of kidney damage and cardiovascular risk in advanced stage of chronic kidney disease,” Kidney & Blood Pressure Research, vol. 41, pp. 231–239, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Karamali, M. Ashrafi, M. Razavi et al., “The effects of calcium, vitamins D and K co-supplementation on markers of insulin metabolism and lipid profiles in vitamin D-deficient women with polycystic ovary syndrome,” Experimental and Clinical Endocrinology & Diabetes, vol. 125, pp. 316–321, 2017. View at Publisher · View at Google Scholar
  66. B. Maestro, S. Molero, S. Bajo, N. Dávila, and C. Calle, “Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3),” Cell Biochemistry and Function, vol. 20, pp. 227–232, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. I. N. Sergeev and W. B. Rhoten, “1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line,” Endocrinology, vol. 136, pp. 2852–2861, 1995. View at Publisher · View at Google Scholar · View at Scopus
  68. N. Sakamoto, I. Wakabayashi, and K. Sakamoto, “Low vitamin K intake effects on glucose tolerance in rats,” International Journal for Vitamin and Nutrition Research, vol. 69, pp. 27–31, 1999. View at Publisher · View at Google Scholar
  69. M. Yoshida, P. F. Jacques, J. B. Meigs et al., “Effect of vitamin K supplementation on insulin resistance in older men and women,” Diabetes Care, vol. 31, pp. 2092–2096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. G. Crepaldi and S. Maggi, “Epidemiologic link between osteoporosis and cardiovascular disease,” Journal of Endocrinological Investigation, vol. 32, pp. 2–5, 2009. View at Google Scholar
  71. M. Razavi, M. Jamilian, M. Karamali, F. Bahmani, E. Aghadavod, and Z. Asemi, “The effects of vitamin D-K-calcium co-supplementation on endocrine, inflammation, and oxidative stress biomarkers in vitamin D-deficient women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial,” Hormone and Metabolic Research, vol. 48, pp. 446–451, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Lips, A. Wiersinga, F. C. Ginkel et al., “The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects,” The Journal of Clinical Endocrinology and Metabolism, vol. 67, pp. 644–650, 1988. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Peacock, “Calcium metabolism in health and disease,” Clinical Journal of the American Society of Nephrology, vol. 5, Supplement 1, pp. S23–S30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. H. A. Bischoff, H. B. Stahelin, W. Dick et al., “Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial,” Journal of Bone and Mineral Research, vol. 18, pp. 343–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. D. Uyl, M. T. Nurmohamed, L. H. Tuyl, H. G. Raterman, and W. F. Lems, “(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis,” Arthritis Research & Therapy, vol. 13, article R5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. S. K. Seo, B. H. Yun, E. B. Noe, J. W. Suh, Y. S. Choi, and B. S. Lee, “Decreased bone mineral density is associated with coronary atherosclerosis in healthy postmenopausal women,” Obstetrics & Gynecology Science, vol. 58, pp. 144–149, 2015. View at Publisher · View at Google Scholar
  77. R. Zhou, H. Zhou, M. Cui et al., “Association between aortic calcification and the risk of osteoporosis in a Chinese cohort: the Chongqing osteoporosis study,” Calcified Tissue International, vol. 93, pp. 419–425, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. A. J. Ballegooijen, R. T. Gansevoort, H. J. Lambers-Heerspink et al., “Plasma 1,25-dihydroxyvitamin D and the risk of developing hypertension: the prevention of renal and vascular end-stage disease study,” Hypertension, vol. 66, pp. 563–570, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Coates, G. S. Kirkland, R. B. Dymock et al., “Cutaneous necrosis from calcific uremic arteriolopathy,” American Journal of Kidney Diseases, vol. 32, pp. 384–391, 1998. View at Google Scholar
  80. G. Arseculeratne, A. T. Evans, and S. M. Morley, “Calciphylaxis--a topical overview,” Journal of the European Academy of Dermatology and Venereology, vol. 20, pp. 493–502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. S. U. Nigwekar, D. B. Bloch, R. M. Nazarian et al., “Vitamin K-dependent carboxylation of matrix Gla protein influences the risk of calciphylaxis,” Journal of the American Society of Nephrology, vol. 28, no. 6, pp. 1717–1722, 2017. View at Publisher · View at Google Scholar
  82. P. A. Galloway, R. El-Damanawi, V. Bardsley et al., “Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease,” Nephron, vol. 129, pp. 197–201, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. T. Sato, L. J. Schurgers, and K. Uenishi, “Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women,” Nutrition Journal, vol. 11, p. 93, 2012. View at Publisher · View at Google Scholar · View at Scopus